Radical hysterectomy for stage IB1 vs IB2 carcinoma of the cervix: Does the new staging system predict morbidity and survival?

Gynecologic Oncology

Volumn 62, Issue 2, 1996, Pages 139-147

  Finan, Michael A ^a   DeCesare, Stephen ^b   Fiorica, James V ^b   Chambers, Richard ^c   Hoffman, Mitchel S ^b   Kline, Richard C ^a   Roberts, William S ^b   Cavanagh, Denis ^b  

^a OCHSNER CLINIC FOUNDATION   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c OCHSNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MORBIDITY; PELVIS LYMPHADENECTOMY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; RADICAL HYSTERECTOMY; RETROSPECTIVE STUDY; TUMOR VOLUME; UTERINE CERVIX CARCINOMA;

EID: 0030220755     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.0206     Document Type: Article

References (25)

1. 1. Delgado, G., Bundy, B., Zaino, R., Sevin, B.-U., Creasman, W. T., and Major, F. Prospective surgical - pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study, Gynecol. Oncol. 38, 352-357 (1990).
2. 2. Chung, C. K., Nahhas, W. A., Stryker, J. A., Curry, S. L., Abt, A. B., and Mortel, R. Analysis of factors contributing to treatment failures in stages IB and IIA carcinoma of the cervix, Am. J. Obstet. Gynecol. 138, 550-556 (1980).
3. 3. Gauthier, P., Gore, I., Shingleton, H. M., Soong, S.-J., Orr, J. W., Jr., and Hatch, K. D. Identification of histopathologic risk groups in stage IB squamous cell carcinoma of the cervix, Obstet. Gynecol. 66, 569-574 (1985).
4. 4. Alvarez, R. D., Soong, S.-J., Kinney, W. K., Reid, G. C., Schray, M. F., Podratz, K. C., Morley, G. W., and Shingleton, H. M. Identification of prognostic factors and risk groups in patients found to have nodal metastasis at the time of radical hysterectomy for early-stage squamous carcinoma of the cervix, Gynecol. Oncol. 35, 130-135 (1989).
5. 5. Creasman, W. T., Soper, J. T., and Clarke-Pearson, D. Radical hysterectomy as therapy for early carcinoma of the cervix, Am. J. Obstet. Gynecol. 155, 964-996 (1986).
6. 6. Alvarez, R. D., Gelder, M. S., Gore, H., Soong, S.-J., and Partridge, E. E. Radical hysterectomy in the treatment of patients with bulky early stage carcinoma of the cervix uteri, Surg. Gynecol. Obstet. 176, 539-542 (1993).
7. 7. Creasman, W. T. FIGO news. Modifications in the staging for Stage I vulvar and Stage I cervical cancer, Int. J. Gynecol. Obstet. 50, 215-216 (1995).
8. 8. Creasman, W. T. New gynecologic cancer staging [editorial], Gynecol. Oncol. 58, 157-158 (1995).
9. 9. Piver, M. S., Rutledge, F., and Smith, J. P. Five classes of extended hysterectomy for women with cervical cancer, Obstet. Gynecol. 44, 265-272 (1974).
10. 10. Robert, M. E., and Fu, Y. S. Squamous cell carcinoma of the uterine cervix - A review with emphasis on prognostic factors and unusual variants, Semin. Diagn. Pathol. 7, 173-189 (1990).
11. 11. DiSaia, P. J., and Creasman, W. T. Clinical Gynecologic Oncology, Mosby-Year Book, St. Louis, pp. 71-72 (1993).
12. 12. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observations, J. Am. Stat. Assoc. 53, 457-481 (1958).
13. 13. Mantel, N. Evaluation of survival data and two new rank order statistics arising in its consideration, Cancer Chemother. Rep. 50, 163-170 (1966).
14. 14. Cox, D. R. Regression models and life tables (with Discussion), J. R. Stat. Soc. Bull. 34, 187-202 (1972).
15. 15. Bray, G. A., and Gray, D. S. Obesity. Part 1 - Pathogenesis, West. J. Med. 149, 429-441 (1988).
16. 16. Morris, M. Early cervical carcinoma: Are two treatments better than one? Gynecol. Oncol. 54, 1-3 (1994).
17. 17. Monk, B. J., Cha, D. S., Walker, J. L., Burger, R. A., Ramsinghani, N. S., Manetta, A., DiSaia, P. J., and Berman, M. L. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma, Gynecol. Oncol. 54, 4-9 (1994).
18. 18. Fiorica, J. V., Roberts, W. S., Greenberg, H., Hoffman, M. S., LaPolla, J. P., and Cavanagh, D. Morbidity and survival patterns in patients after radical hysterectomy and postoperative adjuvant pelvic radiotherapy, Gynecol. Oncol. 36, 343-347 (1990).
19. 19. Burke, T. W., Hoskins, W. J., Heller, P. B., Bibro, M. C., Weiser, E. B., and Park, R. C. Prognostic factors associated with radical hysterectomy failure, Gynecol. Oncol. 26, 153-159 (1987).
20. 20. Noguchi, H., Shiozawa, I., Sakai, Y., Yamazaki, T., and Fukuta, T. Pelvic lymph node metastasis of uterine cervical cancer, Gynecol. Oncol. 27, 150-158 (1987).
21. 21. Noguchi, H., Shiozawa, I., Kitahara, T., Yamazaki, T., and Fukuta, T. Uterine body invasion of carcinoma of the uterine cervix as seen from surgical specimens, Gynecol. Oncol. 30, 173-182 (1988).
22. 22. Fuller, A. F., Jr., Elliot, N., Kosloff, C., Hoskins, W. J., and Lewis, J. L., Jr. Determinants of increased risk for recurrence in patients undergoing radical hysterectomy for Stage IB and IIA carcinoma of the cervix, Gynecol. Oncol. 33, 34-39 (1989).
23. 23. Bloss, J. D., Herman, M. L., Mukhererjee, J., Manetta, A., Emma, D., Ramsanghani, N. S., and DiSaia, P. J. Bulky stage IB cervical carcinoma managed by primary radical hysterectomy followed by tailored radiotherapy, Gynecol. Oncol. 47, 21-27 (1992).
24. 24. Larson, D. M., Stringer, C. A., Copeland, L. J., Gershenson, D. M., Malone, J. M., Jr., and Rutledge, F. N. Stage IB cervical carcinoma treated with radical hysterectomy and pelvic lymphadenectomy: Role of adjuvant radiotherapy, Obstet. Gynecol. 69, 378-381 (1987).
25. 25. Soisson, A. P., Soper, J. T., Clarke-Pearson, D. L., Berchuck, A., Montana, G., and Creasman, W. T. Adjuvant radiotherapy following radical hysterectomy for patients with stage IB and IIA cervical cancer, Gynecol. Oncol. 37, 390-395 (1990).